Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Oligodendroglioma × Blood Specimen Collection × Clear all

Sponsor

Conditions

Breast Neoplasms 5 Carcinoma, Non-Small-Cell Lung 4 Papillomavirus Infections 3 Pancreatic Neoplasms 3 Neoplasms 3 Multiple Myeloma 3 Uterine Cervical Neoplasms 2 Triple Negative Breast Neoplasms 2 Lymphoma, Mantle-Cell 2 Lymphoma, Follicular 2 Lymphoma 2 Waldenstrom Macroglobulinemia 1 Uterine Cervical Dysplasia 1 Thymic aplasia 1 Squamous Cell Carcinoma of Head and Neck 1 Osteosarcoma 1 Obesity 1 Neurofibromatosis 1 1 Neuroblastoma 1 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphohistiocytosis, Hemophagocytic 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid, Accelerated Phase 1

Interventions

Temozolomide 14 Bevacizumab 11 Erlotinib Hydrochloride 5 Radiotherapy 4 Carboplatin 4 Irinotecan 3 Immunoglobulin G 3 Disulfides 3 poly ICLC 2 palbociclib 2 etoposide phosphate 2 Vincristine 2 Sunitinib 2 Magnetic Resonance Spectroscopy 2 Everolimus 2 Dasatinib 2 veliparib 1 varlilumab 1 vandetanib 1 trebananib 1 trametinib 1 terameprocol 1 temsirolimus 1 tandutinib 1 selinexor 1 romidepsin 1 picropodophyllin 1 pemigatinib 1 niraparib 1 nintedanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡